The use of acellular matrices for the tissue engineering of cardiac valves

Proceedings of the Institution of Mechanical Engineers, Part H: Journal of Engineering in Medicine

Volumn 222, Issue 1, 2008, Pages 129-143

  Knight, Rich L ^a   Wilcox, H E ^a   Korossis, S A ^a   Fisher, J ^a   Ingham, E ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Heart valve; Tissue engineering; Xenogeneic

Indexed keywords

BIODEGRADABLE POLYMERS; BIOMECHANICS; BIOMEDICAL ENGINEERING; CARDIOLOGY; HEART; REPAIR; SCAFFOLDS (BIOLOGY); TISSUE; TISSUE REGENERATION;

CARDIAC VALVES; HEART VALVES; OPTIMAL DECELLULARIZATION TECHNIQUE; XENOGENEIC;

TISSUE ENGINEERING;

ANIMAL; BIOPROSTHESIS; CELL FREE SYSTEM; CULTURE TECHNIQUE; CYTOLOGY; EXTRACELLULAR MATRIX; HEART MUSCLE CELL; HEART VALVE PROSTHESIS; HUMAN; PHYSIOLOGY; PROSTHESIS; REVIEW; TISSUE ENGINEERING; ULTRASTRUCTURE;

ANIMALS; BIOPROSTHESIS; CELL CULTURE TECHNIQUES; CELL-FREE SYSTEM; EXTRACELLULAR MATRIX; HEART VALVE PROSTHESIS; HUMANS; MYOCYTES, CARDIAC; PROSTHESIS DESIGN; TISSUE ENGINEERING;

BIOLOGICAL PROPERTIES; BIOMECHANICAL PROPERTIES; CARDIAC VALVE PROSTHESIS; HEART VALVES; PHYSICAL ENVIRONMENTS; TISSUE ENGINEERING SCAFFOLD; TISSUE-ENGINEERED HEART; XENOGENEIC;

EID: 42049090414     PISSN: 09544119     EISSN: None     Source Type: Journal    
DOI: 10.1243/09544119JEIM230     Document Type: Review

References (101)

1. DeWall, R. A., Qasim, N., and Carr, L. Evolution of mechanical heart valves. Ann. Thoracic Surg., 2000, 69, 1612-1621.
2. Senthilnathan, V., Treasure, T., Grunkemeler, G., and Starr, A. Heart valves: which is the best choice? Cardiovascular Surg., 1999, 7, 393-397.
3. Cedars-Sinai Health System, Los Angeles. Cedars-Sinai Medical Centre prosthetic heart valve information page. Available from http:// www.csmc.edu/, 2006.
4. Wang, J. H. The design simplicityand clinical elegance of the St Jude medical heart valve. Ann. Thoracic Surg., 1989, 48, S55-S56.
5. Dohmen, P. M., Scheckel, M., Stein-Konertz, M., Erdbruegger, W., Affeld, K., and Konertz, W. In vitro hydrodynamics of a decellularized pulmonary porcine valve, compared with a glutaraldehyde and polyurethane heart valve. Int. J. Artif. Organs, 2002, 25, 1089-1094.
6. Vitale, N., Hornung, T., Ciotti, G., Hamilton, J. R. L., Pozzi, M., and Hasan, A. The Ross procedure in children under ten years of age. J. Heart Valve Dis., 1999, 8, 601-604.
7. Korossis, S. A., Fisher, J., and Ingham, E. Cardiac valve replacement: a bioengineering approach. Biomed. Mater. Engng,. 2000, 10, 83-124.
8. Schoen, F. J., Levy, R. J., and Piehler, R. Pathological considerations in replacement cardiac valves. Cardiovascular Pathology, 1992, 1, 29-52.
9. Schoen, F. J. Tissue engineered heart valves: the problem defined by stiucture-function-pathology correlations in natural and replacement valves. Tissue engineering for heart valve bioprostheses. In Proceedings of the Satellite Symposium of the World Symposium on Heart valve disease, Westminster, London, 11 June 1999, abstract, pp. 10-12 (University of Padua, Italy).
10. Turentine, M. W., Ruzmetov, M., Vijay, P., Bills, R. G., and Brown, J. W. Biological versus mechanical aortic valve replacement in children. Ann. horacic Surg., 2001, 71, S856-S360.
11. Laudito, A., Brook, M. M., Suleman, S., Bleiweis, M. S., Thompson, L D., Hanley, E L., and Reddy, V. M. The Ross procedure in children and young adults: a word of caution. J. Thoracic Cardiovascular Surg., 2001, 122, 147-153.
12. Sutton, J. P., Ho, S. Y., and Anderson, R. H. The forgotten interleaflet triangles: a review of the surgical anatomy of the aortic valve. Ann. Thoracic Surg., 1995, 59, 419-427.
13. Davila, J. C. Where is the ideal heart valve substitute? What has frustrated its realization? Ann. Thoracic Surg., 1989, 48, S20-S23.
14. Messier, R. H., Bass, B. L., Aly, H. M., Jones, J. L., Domkowski, P. W., Wallace, R. B., and Hopkins, R. A. Dual structure and functional phenotypes of the porcine aortic valve interstitial population: characteristics of the leaflet myofibroblast. J. Surg. Res., 1994, 57, 1-21.
15. Lester, W., Rosenthal, A., Granton, B., and Gotlieb, A. I. Porcine mitral valve interstitial cells in culture. Lab. Invest., 1988, 59, 710-719.
16. Roy, A., Brand, N. J., and Yacoub, M. H. Molecular characterization of the interstitial cells isolated from human heart valves. J. Heart Valve Dis., 2000, 9, 459-465.
17. Taylor, P. M., Allen, S. P., and Yacoub, M. H. Phenotypic and functional characterization of interstitial cells from human heart valves, pericardium. and skin. J Heart Valve Dis., 2000, 9, 150-158.
18. Rabkin, E., Hoerstrup, S. P., Alkawa, M., Mayer, J. E., and Schoen, F. J. Evolution of cell phenotype and extracellular matrix in tissue-engineered heart valves during in vitro maturation and in vivo remodeling. J. Heart Valve Dis., 2002, 11, 308-314.
19. Bachetti, T. and Morbidelli, L. Endothelial cells in culture: a model for studying vascular functions. Pharmacol Res., 2000, 42, 9-19.
20. Deck, J. D., Thubrikar, M. J., Schneider, P. J., and Nolan, S. P. Structure, stress, and tissue repair in aortic valve leaflets. Cardiovascular Res., 1988, 22, 7-16.
21. Weind, K. L., Ellis, C. G., and Boughner, D. R. The aortic valve blood supply. J. Heart Valve Dis., 2000, 9, 1-8.
22. Grunkemeler, G. and Rahimtoola, S. H. Artificial heart valves. A. Rev. Medicine, 1990, 41, 251-263.
23. Sauren, A. H. J. and Van Hout, M. C. The mechanical properties of porcine aortic valve tissues. J. Biomechanics, 1983, 16, 327-337.
24. Broom, N. D. The stress strain behaviour of glutaraldehyde preserved heart valve Tissue. J. Biomechanics, 1977, 10, 707-724.
25. Korossis, S. A., Booth, C., Wilcox, H. E., Watterson, K. G., Kearney, J. N., Fisher, J., and Ingham, E. Tissue engineering of cardiac valve prostheses II: biomechanical characterization of decellularized porcine aortic heart valves. J. Heart Valve Dis., 2002, 11, 463-471.
26. Fung, Y. C. B. Biomechanics, mechanical properties of living tissues, 2nd edition, 1993 (Springer-Verlag, New York).
27. Van de Velde, M. and Klekens, P. Biopolymers: overview of several properties and consequences on their applications. Polym. Testing, 2002, 21, 433-442.
28. Mol, A., Rutten, M. C. M., Driessen, N. J. B., Bouten, C. V. C., Zünd, G., Baaijens, F. P T., and Hoerstrup, S. P. Autologous human tissue-engineered heart valves: prospects for systemic application. Circulation, 2006, 114, suppl. I, I-152-I-158.
29. Thubrikar, M., Bosher, P. L., and Nolan, S. P. The mechanism of opening of the aortic Valve. J. Thoracic Cardiovascular Surg., 1977, 77, 863-870.
30. Rahkin, E. and Schoen, F. J. Cardiovascular tissue engineering. Cardiovascular Pathology, 2002, 11, 305-317.
31. Bader, A., Schilling, T., Teebken, O. E., Brandies, G., Herden, T., Steinhoff, G., and Haverich, A. Tissue engineering of heart valves - human endothelial cell seeding of detergent acellularized porcine valves. Eur J. Cardiovascular Thoracic Surg., 1998, 14, 279-284.
32. Hoerstrup, S. P., Zund, G., Ye, Q., Schoeberlein, A., Schmid, A. C., and Turina, M. I. Tissue engineering of a prosthetic heart valve: stimulation of extracellular matrix assessed by hydroxyproline assay. ASAIO J., 1999, 45, 397-402.
33. O'Brien, M. F., Goldstein, S., Walsh, S., Black, K. S., Elkins, R., and Clarke, D. The SynerGraft valve: a new acellular (nongluteraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. Semin Thoracic Cardiovascular Surg., 1999, 11, Suppl. 1, 194-200.
34. O'Brien, K., Muskiewicz, K., and Gussoni, E. Recent advances in therapeutic potential of muscle-derived stem cells. J. Cell. Biochemistry, 2002, 38, 80-87.
35. Sodian, R., Hoerstrup, S. P., Sperling, J. S., Daebritz, S. H., Martin, D. P., Schoen, R J., Vacanti, J. P., and Mayer, J. E. Tissue engineering of heart valves: in vitro experiences: Ann. Thoracic Surg., 70, 140-144.
36. Sodian, R., Hoerstrup, S. P., Sperling, J. S., Daebritz, S. H., Martin, D. P., Moran, A. M., Kim, B. S., Schoen, F. J., Vacanti, J. P., and Mayer, J. E. Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation, 2000, 102, Suppl. III, 22-29.
37. Elkins, R. C., Dawson, P. E., Goldstein, S., Walsh, S. P., and Black, K. S. Decellularized human valve allografts. Ann. Thoracic Surg., 2001, 71, S428-S432.
38. Jockenhoevel, S., Chalabi, K., Sachweh, J. S., Groesdonk, H. V., Demircan, L., Grossmann, M., Zund, G., and Messmer, B. J. Tissue engineering: complete autologous valve conduit - a new moulding technique. Thoracic Cardiovascular Surg., 2001, 49, 287-290.
39. Kim, W. G., Cho, S. K., Kang, M.-C., Lee, T.-Y., and Park, J. K. Tissue-engineered heart valve leaflets: an animal study. Int. J. Artif. Organs, 2001, 24, 642-648.
40. Cebotari, S., Mertsching, H., Kallenbach, K., Kostin, S., Repin, O., Batrinac, A., Kleczka, C., Ciubotaru, A., and Haverich, A. Construction of autologous human heart valves based on an acellular allograft matrix. Circulation, 2002, 106, Suppl. I, I-63-I-68.
41. Rothenburger, M., Volker, W., Vischer, P., Berendes, E., Glasmacher, B., Scheld, H. H., and Deiwick, M. Tissue engineering of heart valves: formation of a three-dimensional tissue using heart valve cells. ASAIO J., 2002, 48, 586-591.
42. Shinoka, T. Tissue engineered heart valves: autologous cell seeding on biodegradable polymer scaffold. Artificial Organs, 2002, 26, 402-406.
43. Taylor, P M., Allen, S. P., Dreger, S. A., and Yacoub, M. H. Human cardiac valve interstitial cells in collagen sponge: a biological three-dimensional matrix for tissue engineering. J. Heart Valve Dis., 2002, 11, 298-307.
44. Perry, T. E. and Roth, S. J. Cardiovascular tissue engineering: constructing living cardiac valves and blood vessels using bone marrow, umbilical cord blood, and peripheral blood cells. J. Cardiovascular Nurs., 2003, 18, 30-37.
45. Stock, U., Nagashima, M., Khalil, P. N., Nollert, G. D., Herden, T., Sperling, J. S., Moran, A., Lien, J., Martin, D. P., Schoen, F. J., Vacanti, J. P., and Mayer, J. E. Tissue-engineered valved conduits in the pulmonary circulation. J. Thoracic Cardiovascular Surgery, 2000, 119, 732-740.
46. Hoerstrup, S. P., Sodian, R., Daebritz, S., Wang, J., Bacha, E. A., Martin, D. P., Moran, A. M., Guleserian, K. J., Sperling, J. S., Kaushal, S., Vacanti, J. P, Schoen, F. J., and Mayer, J. E. Functional living trileaflet heart valves grown in vitro. Circulation, 2000, 102, Suppl. III, III-44-III-49.
47. Sodian, R., Lueders, C., Kraemer, L., Kuebler, W., Shakibaei, M., Reichart, B., Daebritz, S., and Hetzer, R. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells. Ann. Thoracic Surg., 2006, 81, 2207-2216.
48. Sutherland, F. W. H., Perry, T. E., Yu, Y., Sherwood, M. C., Rabkin, E., Masuda, Y., Garcia, A., McLellan, D. L, Engelmayr, G. C., Sacks, M. S., Schoen, F. J., and Mayer, J. E. From stem cells to viable autologous semilunar heart valve. Circulation, 2005, 111, 2783-2791.
49. van Lieshout, M., Peters, G., Rutten, M., and Baaijens, F. A knitted, fibrin-covered polycaprolactone scaffold for tissue engineering of the aortic valve. Tissue Engng, 2006, 12, 481-487.
50. Rothenburger, M., Vischer, P., Volker, W., Glasmacher, B., Berendes, E., Scheld, H. H., and Detwick, M. Ih vitro modelling of tissue using isolated vascular cells on a synthetic collagen matrix as a substitute for heart valves. Thoracic Cardiovascular Surg., 2001, 49, 204-209.
51. Zünd, G,. Breuer, T., Shinoka, T., Ma, P. X., Langer, R., Mayer. J. E., and Vacanti, J. P. The in vitro construction of a tissue engineered bioprosthetic heart valve. Eur J. Cardiovascular Thoracic Surg., 1997, 11, 493-497.
52. Shinoka, T., Ma, P. X., Shum-Tim, D., Breuer, C. K., Cusick, R. A., Zund, G., Langer, R., Vacanti, J. P., and Mayer, J. E. Tissue-engineered heart valves: autologous valve leaflet replacement study in a lamb model. Circulation, 1996, 94, Suppl. II, III64-III68.
53. Shinoka, T., Shum.-Tim, D., Ma, P. X., Tanel, R. E., Langer, R., Vacand, J. P., and Mayer, J. E. Tissue-engineered heart valve leaflets: does cell origin affect outcome. Circulation, 1997, 96, Suppl. II, II102-II107.
54. Booth, C., Korossis, S. A., Wilcox, H. E., Watterson, K. G., Kearney, J. N., Fisher, J., and Ingham, E. Tissue engineering of cardiac valve prostheses I: development and histological characterization of an acellular porcine scaffold. J. Heart Valve Dis., 2002, 11, 457-462.
55. Kasimir, M. T., Rieder, E., Seebacher, G., Silberhumer, G., Wolner, E., Weigel, G., and Simon, P. Comparison of different decellularization procedures of porcine heart valves. Int. J. Artif. Organs, 2003, 26, 421-427.
56. Steinhoff, G., Stock, U., Karim, N., Mertsching, H., Timke, A., Meliss, R. R., Pethig, K., Haverich, A., and Bader, A. Tissue engineering of pulmonary heart valves on allogenic acellular matrix conduits: in vivo restoration of valve tissue. Circulation, 2000, 102, III50-III55.
57. Kim, W. G., Park, J. K., and Lee. W. Y. Tissue-engineered heart valve leaflets: an effective method of obtaining acellularized valve xenografts. Int. J. Artif. Organs, 2002, 25, 791-797.
58. Curtil, A., Pegg, D. E., and Wilson, A. Freeze drying of cardiac valves in preparation for cellular repopulation. Cryobiology, 1997, 34, 13-22.
59. Meyer, S. R., Nagendran, J., Desal, L. S., Rayat, G. R., Churchill, T. A., Anderson, C. C., Rajotte, R. V., Lakey, J. R., and Ross, D. B. Decellularization reduces the immune response to aortic valve allografts in the rat. J. Thoracic Cardiovascular Surg., 2005, 130, 469-476.
60. Stryer, L. Exploring proteins. In Biochemistry, 3rd edition, 1988, pp. 41-70 (W H. Freeman and Company, New York).
61. Bhairi, S. M. A guide to the properties and uses of detergents in biology and biochemistry, 2001 (Calbiochem-Novabiochem Corporation, La Jolla, California).
62. Lodish, H. Transport across cell membranes. In Molecular cell biology, 4th edition, 2000, pp. 633-664 (W. H. Freeman and Company, New York).
63. Courtman, D. W., Pereira, C. A., Kashef, V., McComb, D., Lee, J. M., and Wilson G. J. Development of a pericardial acellular matrix biomaterial: biochemical and mechanical effects of cell extraction. J. Biomed. Mater Res., 1994, 28, 655-666.
64. Grauss, R. W., Hazekamp, M. G., van Vllet, S., Gittenberger-de Groot, A. C., and DeRuiter, M. C. Decellularization of rat aortic valve allografts reduces leaflet destruction and extracellular matrix remodeling. J. Thoracic Cardiovascular Surg., 2003, 126, 2003-2010.
65. Gross, J. M. Calcification of bioprosthetic heart valves and its assessment. J. Thoracic Cardiovascular Surg., 2001, 121, 428-430.
66. Flameng, W. J., Ozaki, S., Yperman, J., Herijgers, P., Meuris, B., Van Lommel, A., and Verbeken, E. Calcification characteristics of porcine stented valves in a juvenile sheep model. Ann. Thoracic Surg., 2001, 71, S401-S405.
67. Leyh, R. G., Wilhelmi, M., Rebe, P., Fischer, S., Kofidis, T., Haverich, A., and Mertsching, H. In vivo repopulation of xenogeneic and allogeneic acellular valve matrix conduits in the pulmonary circulation. Ann. Thoracic Surg., 2003, 75, 1457-1463.
68. Schenke-Layland, K., Vasilevski, O., Opitz, F., Konig, K., Riemann, I., Halbhuber, K. J., Wahlers, T., and Stock, U. A. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. J. Struct. Biol., 2003, 143, 201-208.
69. Schenke-Layland, K., Opitz, F., Gross, M., Doring, C., Halbhuber, K. J., Schirrmeister, F., Wahlers, T., and Stock, U. A. Complete dynamic repopulation of decellularized heart valves by application of defined physical signals - an in vitro study. Cardiovascular Res., 2003, 60, 497-509.
70. Schenke-Layland, K., Riemann, I., Opitz, F., Konig, K., Halbhuber, K. J., and Stock, U. A. Comparative study of cellular and extracellular matrix composition of native and tissue engineered heart valves. Matrix Biology, 2004, 23, 113-125.
71. Teebken, O., Mertsching, H., and Haverich, A. Modification of heart valve allografts and xenografts by means of tissue engineering. Transplantation Proc., 2002, 34, 2333.
72. Bodnar, E., Olsen, E. G. J., Florio, R., and Dobrin, J. Damage of porcine aortic-valve tissue caused by the surfactant sodium dodecyl sulfate. Thoracic Cardiovascular Surg., 1986, 34, 82-85.
73. Samouillan, V., Dandurand-Lods, J., Lamure, A., Maurel, E., Lacabanne, C., Gerosa, G., Venturini, A., Casarotto, D., Gherardini, L., and Spina, M. Thermal analysis characterization of aortic tissues for cardiac valve bioprostheses. J. Biomed. Mater Res., 1999, 46, 531-538.
74. Kawazoye, S., Tian, S. F., Toda, S., Takashima, T., Sunaga, T., Fujitani, N., Higashino, H., and Matsumura, S. The mechanism of interaction of sodium dodecyl sulfate with elastic fibers. J. Biochemistry, 1995, 117, 1254-1260.
75. Tudorache, I., Cebotari, S., Sturz, G., Kirsch, L., Hurschler, C., Hilfiker, A., Haverich, A., and Lichtenberg, A. Tissue engineering of heart valves: biomechanical and morphological properties of decellularized heart velves. J. Heart Valve Dis., 2007, 16, 567-574.
76. Wilcox, H. E., Korossis, S. A., Booth, C., Watterson, K. G., Kearney, J. N., Fisher, J., and Ingham, E. Biocompatibility and recellularization potential of an acellular porcine heart valve matrix. J. Heart Valve Dis., 2005 14, 228-237.
77. Korossis, S. A., Wilcox, H. E., Watterson, K. G., Kearney, J. N., Ingham, E., and Fisher, J. In-vitro assessment of the functional performance of the decellularized intact porcine aortic root. J. Heart Valve Dis., 2005, 14, 408-421.
78. Knight, R. L., Booth, C., Wilcox, H. E., Fisher, J., and Ingham, E. Tissue engineering of cardiac valves: re-seeding of acellular porcine aortic valve matrices with human mesenchymal progenitor cells. J. Heart Valve Dis., 2005, 14, 806-813.
79. Knight, R. L., Wilcox, H. E., Hunt, J., Booth, C., Watterson, K. G., Kearney J. N. Fisher J., and Ingham, E. In vivo biocompatibility of a decellularised xenogeneic porcine aortic valve matrix. In Proceedings of the Third Biennial Meeting of the Society for Heart Valve Disease, Vancouver, Canada, 17-20 June 2005, poster 1, p. 200 (Society for Heart Valve Disease, London).
80. Paniagua, J. R., Wilcox, H. E., Korossis, S. A, Mirsadraee, S., Lopes, S. V., Costa, F. A., Watterson, K. G., and Ingham-Fisher, E. Decellularised porcine valve conduits; preliminary findings following implantation into a juvenile sheep model. In Proceedings of the Third Biennial Meeting of the Society for Heart Valve Disease, Vancouver, Canada, 17-20 June 2005, poster 2, p. 201 (Society for Heart Valve Disease, London).
81. Goldstein, S., Clarke, D. R., Walsh, S. P., Black, K. S., and O'Brien, M. F. Transpecies heart valve transplant: advanced studies of a bioengineered xeno-autograft. Ann. Thoracic Surg., 2000, 70, 1962-1969.
82. Goldstein, S. Method of preparing transplant tissue to reduce immunogenicity upon implantation. US Pat. 5,613,982, 25 March 1997.
83. Simon, P., Kasimir, M. T., Seebacher, G., Weigel, G., Ullrich, R., Salzer-Muhar, U., Rieder, E., and Wolner, E. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J. Cardiothoracic Surg., 2003, 23, 1002-1006.
84. Kasimir, M. T., Rieder, E., Seebacher, G., Wolner, E., Weigel, G., and Simon, P. Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves. Tissue Engng, 2005, 11, 1274-1280.
85. Elkins, R. C., Goldstein, S., Hewitt, C. W., Walsh, S. P., Dawson, P. E., Ollerenshaw, J. D., Black, K. S., Clarke, D. R., and O'Brien, M. F. Recellularization of heart valve grafts by a process of adaptive remodeling. Semin. Thoracic Cardiovascular Surg., 13, 87-92.
86. Sievers, H. H., Stierle, U., Schmidtke, C., and Bechtel, M. Decellularized pulmonary homograft (SynerGraft) for reconstruction of the right ventricular outflow tract: first clinical experience. Z. Kardiol., 2003, 92, 53-59.
87. Hawkins, J. A., Hillman, N. D., Lambert, L. M., Jones, J., Di Russo, G. B., Profaizer, T., Fuller, T. C., Minich, L. L., Williams, R. V., and Shaddy, R. E. Immunogenicity of decellularized cryopreserved allografts in pediatric cardiac surgery: comparison with standard cryopreserved allografts. J. Thoracic Cardiovascular Surg., 2003, 126, 247-252.
88. Bechtel, J. F., Muller-Steinhardt, M., Schmidtke, C., Brunswik, A., Stierle, U., and Sievers, H. H. Evaluation of the decellularized pulmonary valve homograft (SynerGraft), J. Heart Valve Dis., 2003, 12, 734-739.
89. Bechtel, J. F., Gellissen, J., Erasmi, A. W., Petersen, M., Hiob, A., Stierle, U., and Sievers, H. H. Mid-term findings on echocardiography and computed tomography after RVOT-reconstruction: comparison of decellularized (SynerGraft) and conventional allografts. Eur. J. Cardiothoracic Surg., 2005, 27, 410-415.
90. Tavakkol, Z., Gelehrter, S., Goldberg, C. S., Bove, E. L., Devaney, E. J., and Ohye, R. G. Superior durability of SynerGraft pulmonary allografts compared with standard cryopreserved allografts. Ann. Thoracic Surg., 2005, 80, 1610-1614.
91. Zehr, K. J., Yagubyan, M., Connolly, H. M., Nelson, S. M., and Schaff, H. V. Aortic root replacement with a novel decellularized cryopreserved aortic homograft: postoperative immunoreactivity and early results. J. Thoracic Cardiovascular Surg., 2005, 130, 1010-1015.
92. Konertz, W., Dohmen, P. M., Liu, J., Beholz, S., Dushe, S., Posner, S., Lembcke, A., and Erdbrugger, W. Hemodynamic characteristics of the Matrix P decellularized xenograft for pulmonary valve replacement during the Ross operation. J. Heart Value Dis., 2005, 14, 78-81.
93. Erdbrugger, W., Konertz, W., Dohmen, P. M., Posner, S., Ellerbrok, H., Brodde, O.-E., Robenek, H., Modersohn, D., Pruss, A., Holinski, S., Stein-Konertz, M., and Pauli, G. Decellularized xenogenic heart valves reveal remodelling and growth potential in vivo. Tissue Engng, 2006, 12, 2059-2068.
94. Dohmen, P. M., Ozaki, S., Verbeken, E., Laube, H., Yperman, J., Meuris, B., Flameng, W., and Konertz, W. Tissue engineered auto-xenograft heart valve. Cardiovascular Surg., 2000, 8, 36.
95. Dohmen, P. M., Ozaki, S., Yperman, J., Flameng, W., and Konertz, W. Lack of calcification of tissue engineered heart valves in juvenile sheep. Semin. Thoracic Cardiovascular Surg., 2001, 13, 93-98.
96. Dohmen, P. M., Ozaki, S., Verbeken, E., Yperman, J., Flameng, W., and Konertz, W. F. Tissue engineering of an auto-xenograft pulmonary heart valve. Asian Cardiovascular Thoracic Ann., 2002, 10, 25-30.
97. Dohmen, P. M., Ozaki, S., Nitsch, R., Yperman, J., Flameng, W., and Konertz, W. A tissue engineered heart valve implanted in a juvenile sheep model. Med. Sci. Monitor, 2003, 9, BR97-BR104.
98. da Costa, F. D., Dohmen, P. M., Lopes, S. V., Lacerda, G., Pohl, F., Vilani, R., Affonso Da Costa, M. B., Vieira, E. D., Yoschi, S., Konertz, W., and Affonso da Costa, I. Comparison of cryopreserved homografts and decellularized porcine heterografts implanted in sheep. Artif Organs, 2004, 28, 366-370.
99. Dohmen, P. M., Costa, F., Lopes, S. V., Yoshi, S., Souza, F. P., Vilani, R., da Costa, M. B., and Konertz, W. Results of a decellularized porcine heart valve implanted into the juvenile sheep model. Heart Surg. Forum, 2005, 8, E100-E104.
100. Patience, C., Takeuchi, Y., and Weiss, R. A. Infection of human cells by an endogenous retrovirus of pigs. Nature Medicine, 3, 282-286.
101. Martin, U., Kiessig, V., Blusch, J. H., Haverich, A., von der Helm, K., Herden, T., and Steinhoff, G. Expression of pig endogenous retrovirus by primary porcine endothelial cells and infection of human cells. Lancet, 1998, 352, 692-694.